Bandhan Life Science Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 09-01-2025
- Paid Up Capital ₹ 0.10 M
as on 09-01-2025
- Company Age 9 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -26.71%
(FY 2023)
- Profit -69.64%
(FY 2023)
- Ebitda -73.70%
(FY 2023)
- Net Worth 10.22%
(FY 2023)
- Total Assets 3.54%
(FY 2023)
About Bandhan Life Science
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shikha Parolia, Harshit Parolia, and Sudarshana Parolia serve as directors at the Company.
- CIN/LLPIN
U74900WB2015PTC206447
- Company No.
206447
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 May 2015
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Bandhan Life Science?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shikha Parolia  | Director | 25-May-2015 | Current |
| Harshit Parolia | Director | 24-Oct-2016 | Current |
| Sudarshana Parolia | Director | 01-Apr-2022 | Current |
Financial Performance of Bandhan Life Science.
Bandhan Life Science Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 26.71% decrease. The company also saw a substantial fall in profitability, with a 69.64% decrease in profit. The company's net worth Soared by an impressive increase of 10.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bandhan Life Science?
Unlock access to Bandhan Life Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
- Huanghe Whirlwind Diamonds (India) Private LimitedActive 19 years 4 months
Shikha Parolia is a mutual person
- Brewix Tea Private LimitedActive 2 years 7 months
Harshit Parolia and Sudarshana Parolia are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bandhan Life Science?
Bandhan Life Science has a workforce of 43 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bandhan Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bandhan Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
